Medical/Pharmaceuticals
The third edition of CIIE is ready to kick off
SHANGHAI, Oct. 30, 2020 /PRNewswire/ -- The third China International Import Expo (CIIE) is entering the final stage of preparations as a huge road paving machine by German company Wirtgen Group became the first exhibit to arrive at the National Exhibition and Convention Center (Shanghai), the ho...
2020-10-30 20:48
4046
Prenetics Acquires Oxsed, Oxford University Spin-out to Scale Rapid COVID-19 Test Globally. Rapid Airport Testing has begun in Heathrow with Trials in Hong Kong International Airport.
* The Oxsed RaViD Direct test kit is highly accurate at 92% - 100%1 sensitivity, and provides a scalable and low-cost COVID-19 test which can be performed anywhere. Results in 15-30 minutes * The acquisition will accelerate global access and availability at reasonable cost, particularly for L...
2020-10-30 16:19
2197
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases
HONG KONG, Oct. 30, 2020 /PRNewswire/ -- October 30, 2020, Ocumension Therapeutics (1477.HK) announced that the Company has entered into a collaboration and exclusive promotion agreement with Shandong Boan Biological Technology Co. Ltd., a wholly-owned subsidiary of Luye Pharma Group Ltd. to joi...
2020-10-30 10:54
6260
AVATAMED and Macrogen sign MOU on joint business in personalized precision medicine services in cancer treatment
SINGAPORE, Oct. 30, 2020 /PRNewswire/ -- AVATAMED (www.avatamed.com
2020-10-30 08:00
2847
AGC Biologics and Horizon Therapeutics plc Expand Partnership
Horizon's TEPEZZA® (teprotumumab-trbw) treatment will be produced from AGC Biologics' new facility inBoulder, CO SEATTLE, Oct. 30, 2020 /PRNewswire/ -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced that its partnership wit...
2020-10-30 03:17
5038
NorthStar Commended by Frost & Sullivan for its RadioGenix(R) System, an Innovative, High-Tech Separation Platform for Processing Non-Uranium-based Mo-99
The RadioGenix® System addresses molybdenum-99 (Mo-99) availability, nuclear proliferation, and environmental concerns to drive the U.S. medical radioisotope industry SANTA CLARA, Calif., Oct. 29, 2020 /PRNewswire/ -- Based on its recent analysis of the North American nuclear medicine imaging ma...
2020-10-29 21:00
1876
Accuhealth Partners With Telli Health To Provide The World's First IoT FDA Approved SpO2 Meter Powered By Sigfox
MCALLEN, Texas, Oct. 29, 2020 /PRNewswire/ -- Accuhealth announced today that they are proud to partner withTelli Health to provide the world's first FDA certified and approved, plug-and-play Sigfox SpO2 meter. Telli Health developed the hardware and Accuhealth bought the first 5,000 units and wi...
2020-10-29 21:00
2028
Frost & Sullivan's 2020 India Best Practices Awards Lauded Companies Showcasing Best Practices in Innovation, Performance, and Growth
19 awards were presented to companies for their exemplary performance at the 7th edition of these Awards MUMBAI, India, Oct. 29, 2020 /PRNewswire/ -- Frost & Sullivan's India Best Practices Awards were hosted on a virtual platform on October 28, 2020. These awards are presented each year to comp...
2020-10-29 20:42
2145
Complete Data from Connect Biopharma's Phase 1b Study of CBP-201 Demonstrate Rapid, Early and Continuous Improvement in Patient Quality of Life and Atopic Dermatitis (AD) Symptoms
Results from study in adult patients with moderate-to-severe AD presented at EADV Congress SAN DIEGO and TAICANG, SUZHOU, China, Oct. 29, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune mo...
2020-10-29 19:00
1828
A Global Push to Increase Awareness, Action and Access to Thrombectomy Care for Stroke Patients is Underway
The Society of Vascular and Interventional Neurology together with MT2020 will distribute a report detailing their global initiative to reduce death and disability in stroke patients MIAMI, Oct. 29, 2020 /PRNewswire/ -- Mission Thrombectomy 2020+ (MT2020+), a global campaign of SVIN (Society of ...
2020-10-29 19:00
1543
Kintor Pharmaceutical's COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment
SUZHOU, China, Oct. 29, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (Kintor Pharmaceutical, stock code 9939.HK) is delighted to announced that the clinical trial (ClinicalTrials.gov identifier: NCT04446429, registered by Dr. Andy Goren and Applied Biology) of its anti-androgen treatment Pro...
2020-10-29 18:24
3805
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa
* Tadekinig alfa is a novel IL-18 binding protein in pivotal Phase 3 testing for orphan disease IL-18 driven monogenic Hemophagocytic Lymphohistiocytosis (HLH) * WuXi Biologics to undertake commercial-scale manufacturing to support U.S. market launch SHANGHAI and LAUSANNE, Switzerland, Oct. 2...
2020-10-29 17:00
2717
Human-Machine Competition: Ping An's AskBob Doctor's AI Matches Doctors' Capabilities in Cardiovascular Disease Management
HONG KONG and SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 02318; SSE: 601318) announced thatPing An's AskBob Doctor has demonstrated that its artificial intelligence (AI) capabilities in cardiovascular disease ...
2020-10-29 16:50
5378
Deep Longevity and SquareOne Wellness Partner on Deep Biomarkers of Aging and Longevity
HONG KONG, Oct. 28, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK) today announced that Deep Longevity, Inc, a company recently acquired by the Group which is a pioneer in deep biomarkers of agin...
2020-10-29 09:57
5277
Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia
SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, today announced that Australian regulatory authorities have approved it...
2020-10-29 09:35
1975
CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate
* CStone to acquire exclusive rights for development and commercialization outsideSouth Korea for LCB71, an ROR1 antibody drug conjugate * Agreement adds to CStone's pipeline a potential first-in-class/best-in-class drug candidate with monotherapy and combination applications for a range of c...
2020-10-29 07:15
3672
BioInvent Completes First Licensing Agreement in Greater China, Advised by MSQ Ventures
NEW YORK, Oct. 29, 2020 /PRNewswire/ -- M.S.Q. Ventures ("MSQ") announced today that its client, BioInvent International, AB ("BioInvent"), has successfully entered into a licensing agreement with CASI Pharmaceuticals, Inc. ("CASI") for the development and commercialization of BI-1206 in theGreat...
2020-10-29 02:51
2857
Daewoong Pharmaceutical's COVID-19 Treatment Candidate Also Highly Effective against Influenza Virus
SEOUL, South Korea, Oct. 28, 2020 /PRNewswire/ -- Daewoong Pharmaceutical, a South Korean pharmaceutical giant announced that its Covid-19 treatment candidate of sustained-release niclosamide (DWRX2003) also showed promising study results for a fight against the upcoming 'Twindemic' involving COV...
2020-10-28 22:36
1559
MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World's Smallest Wristed Surgical Instruments
First Procedures Performed with the Symani Surgical System CALCI, Italy, Oct. 28, 2020 /PRNewswire/ -- MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the CE Mark, launch and first human use of its Symani® Surgical Syste...
2020-10-28 20:00
3017
APRINOIA Announces Approval from NMPA to Initiate Phase 3 Clinical Trial in China for [18F]-APN-1607 Tau PET Imaging Tracer for Dementia
SUZHOU, China, Oct. 28, 2020 /PRNewswire/ -- APRINOIA Therapeutics announced today that China National Medical Products Administration (NMPA) had approved to initiate Phase 3 clinical trial to evaluate APRINOIA's positron emission tomography (PET) imaging tracer, [18F]-APN-1607, targeting abnorma...
2020-10-28 14:00
2285
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7433
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
6834
